KRAS and colorectal neoplasm: In contrast, we along with others have previously shown that oncogenic KRAS promotes apoptosis of human colorectal tumour cells exposed to either 5-FU or oxaliplatin (Klampfer et al, 2005; Smakman et al, 2006).